arsenic trioxide has been researched along with Skin Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Emri, G; Fidrus, E; Hegedűs, C; Janka, EA; Paragh, G; Remenyik, É | 1 |
| Ding, C; Liu, J; Ma, YY; Wang, P | 1 |
| Ally, MS; Atwood, SX; Bailey-Healy, I; Beachy, PA; Chang, AL; Colevas, AD; Kim, J; Oro, A; Ransohoff, K; Rezaee, M; Sarin, K; Tang, JY | 1 |
| Béné, MC; Bonnet, A; Chevallier, P; Garandeau, C; Garnier, A; Guillaume, T; Houreau-Langlard, D; Hourmant, M; Le Gouill, S; Moreau, P; Peterlin, P; Tissot, A; Vantyghem, S | 1 |
| Bi, X; Gu, J; Guo, Z; Mi, Q; Tang, L; Tao, S; Wang, Y; Wu, J | 1 |
| Chang, HH; Chang, KH; Chen, HW; Chen, YJ; Chung, CH; Huang, MJ; Lai, YL; Lin, LH; Su, WH; Wang, WY | 1 |
| Bachelez, H; Degos, L; Dombret, H; Dubertret, L; Dupuy, A; Jean-Louis, F; Michel, L; Musette, P; Poupon, J; Sors, A; Viguier, M | 1 |
| Bedikian, AY; Camacho, LH; Kim, KB; McCullough, C; Papadopoulos, NE | 1 |
| Agarwala, SS; Gooding, WE; Islam, MF; Kirkwood, JM; Tarhini, AA; Tawbi, H | 1 |
| Bael, TE; Gollob, JA; Peterson, BL | 1 |
| Döbbeling, U; Dummer, R; Hassel, JC; Navarini, AA; Oberholzer, PA; Qin, JZ; Tun-Kyi, A | 1 |
5 trial(s) available for arsenic trioxide and Skin Neoplasms
| Article | Year |
|---|---|
Combined effect of topical arsenic trioxide and radiation therapy on skin-infiltrating lesions of breast cancer-a pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Combined Modality Therapy; Female; Gels; Humans; Middle Aged; Oxides; Pilot Projects; Skin Neoplasms | 2003 |
Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).
Topics: Aged; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Caspases; Cell Division; Cell Line, Tumor; Clone Cells; Drug Synergism; Humans; Leukocytes, Mononuclear; Lymphoma, T-Cell, Cutaneous; Middle Aged; Mitochondria; Oxides; Skin Neoplasms | 2003 |
A phase II trial of arsenic trioxide in patients with metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Choroid Neoplasms; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Oxides; Skin Neoplasms; Survival Rate; Treatment Outcome | 2005 |
Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Choroid Neoplasms; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Oxides; Skin Neoplasms | 2008 |
Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Brain Neoplasms; Dacarbazine; Female; Humans; Male; Melanoma; Middle Aged; Oxides; Skin Neoplasms; Temozolomide | 2008 |
6 other study(ies) available for arsenic trioxide and Skin Neoplasms
| Article | Year |
|---|---|
Inhibitors of Nucleotide Excision Repair Decrease UVB-Induced Mutagenesis-An In Vitro Study.
Topics: Animals; Arsenic Trioxide; Autophagy; Benzimidazoles; Cell Cycle Checkpoints; Cell Line, Transformed; Cell Survival; CHO Cells; Cricetulus; DNA Damage; DNA Repair; HaCaT Cells; Humans; Hypoxanthine Phosphoribosyltransferase; Melanoma; Mutation Rate; Pyrimidine Dimers; Resveratrol; Skin; Skin Neoplasms; Spironolactone; Ultraviolet Rays | 2021 |
Multiple Bowen's diseases and basal cell carcinomas in a patient with acute promyelocytic leukemia treated with arsenic trioxide: A case report and effective treatment with photodynamic therapy.
Topics: Antineoplastic Agents; Arsenic Trioxide; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Photochemotherapy; Skin Neoplasms; Treatment Outcome | 2018 |
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Follow-Up Studies; Hedgehog Proteins; Humans; Itraconazole; Male; Middle Aged; Neoplasm Metastasis; Oxides; RNA, Messenger; Skin Neoplasms; Transcription Factors; Treatment Outcome; Zinc Finger Protein GLI1 | 2016 |
Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Humans; Immunocompromised Host; Kidney Transplantation; Leukemia, Promyelocytic, Acute; Lung Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Oxides; Postoperative Complications; Skin Neoplasms; Tretinoin | 2016 |
Different pathways are involved in arsenic-trioxide-induced cell proliferation and growth inhibition in human keratinocytes.
Topics: Adolescent; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Squamous Cell; Caspase 3; Cell Cycle; Cell Enlargement; Cell Line; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Humans; Keratinocytes; Male; Oxides; Skin Neoplasms | 2010 |
Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; bcl-X Protein; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Mice; Mice, Nude; Mycosis Fungoides; Myeloid Cell Leukemia Sequence 1 Protein; NF-kappa B; Oxides; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; STAT5 Transcription Factor; T-Lymphocytes; Xenograft Model Antitumor Assays | 2008 |